Home > Financial Ratios > GENPHARMASEC

GENPHARMASEC
Price to Cash Earnings (PCE)

    Back to All Ratios
GENPHARMASEC is part of below Screeners ↓
Top Undervalued Small Cap Stocks
COMMUNITY POLL
for GENPHARMASEC
Please provide your vote to see the results

GENPHARMASEC Last 5 Year Price to Cash Earnings (PCE) History

[Consolidated]

Mar2025Mar2024Mar2023
   PCE(x) 51.24-970.7575.24

What is the latest Price to Cash Earnings (PCE) ratio of GENPHARMASEC ?

The latest Price to Cash Earnings (PCE) ratio of GENPHARMASEC is 51.24 based on Mar2025 Consolidated results.
Year Price to Cash Earnings (PCE)
Mar202551.24
Mar2024-970.75
Mar202375.24

How is Price to Cash Earnings (PCE) of GENPHARMASEC Trending?

Years Price to Cash Earnings (PCE) % Change
Mar2025 51.24
Positive
Mar2024 -970.75
Negative
Mar2023 75.24 -

Other Financial Ratios of GENPHARMASEC


Compare Price to Cash Earnings (PCE) ratio of peers of GENPHARMASEC

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
GENPHARMASEC ₹70.9 Cr 3.2% -4.4% -57% Stock Analytics
SUDARSHAN CHEMICAL INDUSTRIES ₹6,855.0 Cr -6.2% -8.2% -15.2% Stock Analytics
KIRI INDUSTRIES ₹3,087.9 Cr 8.4% -6.4% -6.3% Stock Analytics
VIDHI SPECIALTY FOOD INGREDIENTS ₹1,637.0 Cr 0.2% 0.3% -22.6% Stock Analytics
SHREE PUSHKAR CHEMICALS & FERTILISERS ₹1,061.5 Cr -1.4% -12.1% 14.8% Stock Analytics
BODAL CHEMICALS ₹617.8 Cr 0% -5.6% -18% Stock Analytics


GENPHARMASEC Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
GENPHARMASEC

3.2%

-4.4%

-57%

SENSEX

-0.4%

-1.7%

9.1%


You may also like the below Video Courses